消化不良

L. Peyrin-Biroulet (Interne des Hôpitaux), M.-A. Bigard (Professeur des Universités, chef de service)
{"title":"消化不良","authors":"L. Peyrin-Biroulet (Interne des Hôpitaux),&nbsp;M.-A. Bigard (Professeur des Universités, chef de service)","doi":"10.1016/j.emchg.2005.01.003","DOIUrl":null,"url":null,"abstract":"<div><p><span>Functional dyspepsia is a chronic and polymorphic disorder with a prevalence of approximately 10% in the adult population. Management of this disease represents a considerable economic burden worldwide. Functional dyspepsia is defined as a pain or a sensation of discomfort located in the upper abdomen, according to the Rome II criteria. A dyspepsia subgroup classification based on the predominant symptom has been proposed: dysmotility-like dyspepsia, ulcer-like dyspepsia and non-specific dyspepsia. In patients with alarm symptoms, upper endoscopy<span> has to be performed. In the absence of alarm features, the patient needs to be reassured and psychotherapy must be discussed. Then, empirical therapy with proton pump inhibitors (ulcer-like dyspepsia) or domperidone (dysmotility-like dyspepsia) may improve symptoms in some cases. Efficacy of </span></span><em>Helicobacter pylori</em> eradication in dyspepsia is probably poor; on the other hand, treatment of <em>Helicobacter pylori</em><span> infection could reduce the prevalence of gastric cancer but further investigations are needed to clarify this point. Pathophysiology of dyspepsia remains unclear. The psychological factors are not the only involved in this functional disorder. The identification of the mechanisms that lead to symptom generation should facilitate the development of newer and more effective therapeutic strategies in functional dyspepsia.</span></p></div>","PeriodicalId":100426,"journal":{"name":"EMC - Hépato-Gastroenterologie","volume":"2 2","pages":"Pages 105-123"},"PeriodicalIF":0.0000,"publicationDate":"2005-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/j.emchg.2005.01.003","citationCount":"0","resultStr":"{\"title\":\"Dyspepsie\",\"authors\":\"L. Peyrin-Biroulet (Interne des Hôpitaux),&nbsp;M.-A. Bigard (Professeur des Universités, chef de service)\",\"doi\":\"10.1016/j.emchg.2005.01.003\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<div><p><span>Functional dyspepsia is a chronic and polymorphic disorder with a prevalence of approximately 10% in the adult population. Management of this disease represents a considerable economic burden worldwide. Functional dyspepsia is defined as a pain or a sensation of discomfort located in the upper abdomen, according to the Rome II criteria. A dyspepsia subgroup classification based on the predominant symptom has been proposed: dysmotility-like dyspepsia, ulcer-like dyspepsia and non-specific dyspepsia. In patients with alarm symptoms, upper endoscopy<span> has to be performed. In the absence of alarm features, the patient needs to be reassured and psychotherapy must be discussed. Then, empirical therapy with proton pump inhibitors (ulcer-like dyspepsia) or domperidone (dysmotility-like dyspepsia) may improve symptoms in some cases. Efficacy of </span></span><em>Helicobacter pylori</em> eradication in dyspepsia is probably poor; on the other hand, treatment of <em>Helicobacter pylori</em><span> infection could reduce the prevalence of gastric cancer but further investigations are needed to clarify this point. Pathophysiology of dyspepsia remains unclear. The psychological factors are not the only involved in this functional disorder. The identification of the mechanisms that lead to symptom generation should facilitate the development of newer and more effective therapeutic strategies in functional dyspepsia.</span></p></div>\",\"PeriodicalId\":100426,\"journal\":{\"name\":\"EMC - Hépato-Gastroenterologie\",\"volume\":\"2 2\",\"pages\":\"Pages 105-123\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2005-04-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://sci-hub-pdf.com/10.1016/j.emchg.2005.01.003\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"EMC - Hépato-Gastroenterologie\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://www.sciencedirect.com/science/article/pii/S1769676305000042\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"EMC - Hépato-Gastroenterologie","FirstCategoryId":"1085","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S1769676305000042","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

摘要

功能性消化不良是一种慢性多形性疾病,在成年人中患病率约为10%。这一疾病的管理是全世界相当大的经济负担。功能性消化不良被定义为位于上腹部的疼痛或不适感,根据Rome II标准。基于主要症状的消化不良亚组分类已被提出:运动障碍样消化不良,溃疡样消化不良和非特异性消化不良。对于有报警症状的患者,必须进行上腔镜检查。在没有报警特征的情况下,患者需要放心,必须讨论心理治疗。然后,质子泵抑制剂(溃疡样消化不良)或多潘立酮(动力障碍样消化不良)的经验性治疗可能在某些情况下改善症状。根除幽门螺杆菌治疗消化不良的疗效可能较差;另一方面,幽门螺杆菌感染的治疗可以降低胃癌的患病率,但这一点需要进一步的研究来阐明。消化不良的病理生理机制尚不清楚。心理因素并不是导致这种功能障碍的唯一因素。识别导致症状产生的机制应该有助于开发更新和更有效的功能性消化不良治疗策略。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
Dyspepsie

Functional dyspepsia is a chronic and polymorphic disorder with a prevalence of approximately 10% in the adult population. Management of this disease represents a considerable economic burden worldwide. Functional dyspepsia is defined as a pain or a sensation of discomfort located in the upper abdomen, according to the Rome II criteria. A dyspepsia subgroup classification based on the predominant symptom has been proposed: dysmotility-like dyspepsia, ulcer-like dyspepsia and non-specific dyspepsia. In patients with alarm symptoms, upper endoscopy has to be performed. In the absence of alarm features, the patient needs to be reassured and psychotherapy must be discussed. Then, empirical therapy with proton pump inhibitors (ulcer-like dyspepsia) or domperidone (dysmotility-like dyspepsia) may improve symptoms in some cases. Efficacy of Helicobacter pylori eradication in dyspepsia is probably poor; on the other hand, treatment of Helicobacter pylori infection could reduce the prevalence of gastric cancer but further investigations are needed to clarify this point. Pathophysiology of dyspepsia remains unclear. The psychological factors are not the only involved in this functional disorder. The identification of the mechanisms that lead to symptom generation should facilitate the development of newer and more effective therapeutic strategies in functional dyspepsia.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信